Phase II: SCLC / other NECs
Phase I: SCLC / NECs expressing DLL3
FOCUS AREA
SMALL CELL LUNG CANCER
GASTROINTESTINAL CANCER
NEUROENDOCRINE NEOPLASMS
DEVELOPMENT STAGE
PHASE I
PHASE II
TARGET
12
Title
Order
3
Subtitle pipeline
Immuno-oncology
SEO Description
DLL3-CD3 T-cell engager